The city of Pittsburgh, Pennsylvania, currently has 221 active clinical trials seeking participants for Cancer research studies.
Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: The VAPOR-C Trial
Recruiting
VAPOR-C is a randomised study of the impact of IV versus inhaled anaesthesia (propofol versus sevoflurane) and lidocaine versus no lidocaine on duration of disease free survival inpatients with either colorectal or non small cell lung cancer.
Gender:
All
Ages:
18 years and above
Trial Updated:
03/21/2023
Locations: University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
Conditions: Colonic Cancer, Rectal Cancer, Non Small Cell Lung Cancer
Detection of Genetic Markers of Lung Cancer
Recruiting
The purpose of this research study is to determine the genetic changes and immunologic changes that are involved in the development and progression of bronchogenic lung cancer.
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
03/08/2023
Locations: Hillman Cancer Center, Pittsburgh, Pennsylvania
Conditions: Lung Cancer
EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Breast CA
Recruiting
The goal of this clinical trial is to learn how a group resistance training plan can improve body mobility and strength in female breast cancer patients who have completed their breast cancer treatment. The main questions it aims to answer are: Is resistance training feasible following breast cancer treatment Can it improve the body's mobility and strength lost as a result of the breast cancer treatment can it improve the body's composition (for example muscle mass) can resistance training incr... Read More
Gender:
Female
Ages:
Between 20 years and 89 years
Trial Updated:
02/25/2023
Locations: Allegheny General Hospital, Pittsburgh, Pennsylvania
Conditions: Breast Cancer Female
CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer
Recruiting
The CORRECT - MRD II study will prospectively enroll patients who have undergone complete surgical resection for stage II or III colorectal cancer. Patients will be followed for a minimum of 3 years and up to 5 years for recurrence.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/01/2023
Locations: UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania
Conditions: Colorectal Cancer
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
Recruiting
The study is a multi-center, un-blinded, randomized control study of subjects with locally advanced pancreatic adenocarcinoma which is unresectable.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/23/2022
Locations: University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
Conditions: Locally Advanced Pancreatic Cancer